Precision Biosensor, Inc.

A335810

KR7335810008

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
4,320 ^KRW	-1.59%		+4.85%	-9.43%

Mar. 25	Qlife Signs Letter of Intent with Precision Biosensor	CI
Feb. 08	Precision Biosensor, Inc. announced that it has received KRW 3 billion in funding from Shinhan Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd.	CI

Precision Biosensor, Inc. announced that it has received KRW 150 billion in funding

November 17, 2021

On November 18, 2021, Precision Biosensor, Inc. closed the transaction.

Latest news about Precision Biosensor, Inc.

Qlife Signs Letter of Intent with Precision Biosensor	Mar. 25	CI
Precision Biosensor, Inc. announced that it has received KRW 3 billion in funding from Shinhan Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd.	Feb. 07	CI
Precision Biosensor, Inc. announced that it expects to receive KRW 3 billion in funding from Shinhan Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd. and another investor	Feb. 05	CI
Precision Biosensor, Inc.(KOSDAQ:A335810) dropped from S&P Global BMI Index	22-09-19	CI
Precision Biosensor, Inc. announced that it has received KRW 150 billion in funding	21-11-17	CI
Precision Biosensor, Inc. announced that it expects to receive KRW 150 billion in funding	21-11-15	CI
Precision Biosensor, Inc.(KOSDAQ:A335810) added to S&P Global BMI Index	21-06-21	CI
Precision Biosensor, Inc. has completed an IPO in the amount of KRW 18.75 billion.	20-12-16	CI
Precision Biosensor, Inc. has filed an IPO.	20-07-23	CI

Chart Precision Biosensor, Inc.

Duration

Period

More charts

PrecisionBiosensor Inc is a Korea-based company mainly engaged in the development, manufacture and sale of in vitro diagnostic reagents. The Company's main products include testers and cartridges. The testers are portable immunoassay diagnostic devices for on-site diagnosis that uses colorimetric and time-resolved fluorescence to check acute heart disease, metabolism, and inflammatory diseases. The cartridges are used in gold absorption and time-resolved fluorescence analysis diagnostic equipment, and can check acute heart disease, metabolism, and inflammatory diseases. The Company sells its products in domestic and overseas markets such as Europe, China, the Middle East, and Southeast Asia.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
PRECISION BIOSENSOR, INC.	-9.43%	36.64M
BIOMÉRIEUX	-1.29%	12.64B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-0.47%	8.46B
DIASORIN S.P.A.	+5.68%	5.66B
LANTHEUS HOLDINGS, INC.	+22.61%	5.27B
AUTOBIO DIAGNOSTICS CO., LTD.	-2.03%	4.49B
10X GENOMICS, INC.	-53.56%	3.11B
ANDON HEALTH CO., LTD.	+19.30%	2.87B
MYRIAD GENETICS, INC.	+33.07%	2.31B
VITROLIFE AB	-8.42%	2.23B

Diagnostic & Testing Substances